Biowatch

Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe

Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe

Samsung Bioepis announced on the 30th that it has signed a patent agreement and licensing contract with the original drug developer for the sale of...
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?

American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment injection drug ‘Lecanemab...
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year

Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year

Samsung Bioepis achieved its highest performance last year in terms of sales. Excluding short-term milestone revenues,...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?

Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?

Generic Drug Price Reduction: How Much Benefit Will It Bring to Patients?

These days, the pharmaceutical industry is focused on the topic of 'drug price reduction.
SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine

SK Bioscience Accelerates Development of Next-Generation Zaire Ebola Vaccine

SK Bioscience is accelerating the development of the next-generation Ebola vaccine with funding support from the...
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears

Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears

Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.
Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Pharmaceutical Industry Establishes Successive R&BD Subsidiaries... Is Yuhan Corporation Joining?

Yuhan Corporation recently announced plans to establish a specialized subsidiary for 'Research and Business Development...
Capture the 0.02% Micro Signal in Blood...Bio Venture GraBis Challenging Early Cancer Diagnosis

Capture the 0.02% Micro Signal in Blood...Bio Venture GraBis Challenging Early Cancer Diagnosis

“If you miss one tiny signal, you could lose a life (Missing one tiny signal Cost a Life).
NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years

NVIDIA and Eli Lilly Establish 'AI Drug Research Institute' with Up to $1.4 Trillion Investment Over 5 Years

Semiconductor company NVIDIA is partnering with global pharmaceutical company Eli Lilly to establish an artificial...